Phytopharm has announced results of its Phase II, randomised trial of Cogane in unmedicated patients with Parkinson's disease. More than four hundred subjects with early-stage Parkinson's disease were randomly chosen to receive either ...
Tags: PhytopharmPhase II, randomised trial, Parkinson's disease
The USFDA has approved Novartis Zortress as the first drug to prevent organ rejection in adult patients receiving liver transplantation in the US. The approval was based on positive data from liver transplant study that compared Zortress ...
Tags: medication, FDA, Zortress
The US Food and Drug Administration (FDA) has approved labeling changes to Bristol-Myers Squibb's Reyataz (atazanavir), an antiretroviral medication. The label will now include warnings about kidney and gall stones in addition to updated ...
mPhase Technologies has submitted a patent application to the US Patent and Trademark Office (USPTO) for its drug delivery system. The application covers a drug delivery system based on the company's Smart Surface technology, which ...
US-based Smiths Medical has gained US marketing rights for its CADD-Solis variable infusion profile (VIP) ambulatory infusion system, following the US Food and Drug Administration (FDA) approval. The multi-therapy infusion system, which ...
Tags: FDA, therapy infusion system, Medical
The software solution is designed for all types of patient interactions within hospitals including after an inpatient discharge, emergency department visit, radiology test, same-day surgery, or specialty procedure. LA GRANGE, IL, February ...
Tags: Smart-ER, Patient Contact System, software
The shortage of doxycycline recently announced by the Food and Drug Administration could leave many people searching for alternatives because the antibiotic is used to treat a wide range of conditions that afflict millions, including acne, ...
Los Angeles-based Targeted Medical Pharma has obtained a notice of issuance for its projected patent number 8370172 from the US Patent and Trademark Office (USPTO). The patent is related to a system and method for submitting claims for a ...
Tags: USPTO, Medical Pharma, patent
UK-based pharmaceutical company Bristol-Myers Squibb and AstraZeneca have announced that the National Institute for Health and Clinical Excellence (NICE) in the UK has issued an Appraisal Consultation Document (ACD) for its first-in-class, ...
Tags: pharmaceutical company, Bristol-Myers Squibb, AstraZeneca, NICE
With cold and flu season peaking, the recall Thursday of 24 varieties of Triaminic and Theraflu Warming Relief syrups due to faulty child-resistant safety caps serves as a reminder to parents that cough and cold medications can be dangerous ...
Medtronic has commenced prospective, open-label, parallel-group PROMISE trial of its neurostimulation therapy device for treating patients with chronic low back pain associated with failed back surgery syndrome (FBSS). The spinal cord ...
Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals
If you suffer from overactive bladder you now have two new options: Botox injections (yes, the wrinkle-shrinking drug), and an over-the-counter version of the Oxytrol patch, which used to require a prescription. The Food and Drug ...
Tags: overactive bladder, Botox injections, healthcare, medical tips
The US FDA has issued marketing approval for Lupin Pharmaceuticals' Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg, the combined oral contraceptive. Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent ...
Tags: FDA, Oral Contraceptive Medication, Lupin Pharmaceuticals
Health Canada has requested all manufacturers of botulinum toxin products to revise their product labels in a bid to help prevent medication errors with their use. According to Health Canada, the new labeling should reflect in such a way ...